
Recent research addresses low positive predictive value (PPV) in nasopharyngeal carcinoma (NPC) screening. Reviewing advancements in NPC early detection and cfDNA methylation, experts propose a breakthrough. Despite efforts, PPV remains at 10%. CfDNA methylation shows high specificity and accuracy in diverse tumors. Integration with EBV testing enhances PPV for NPC screening. The fusion of cfDNA methylation and EBV serology emerges as a crucial strategy to overcome low PPV in NPC early screening.
Like
Save
Share